StockData
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.50−0.28 (-10.07%)

Close on Nov 18, 2026Market cap $23.40MP/E –Yield –

Adicet Bio free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Adicet Bio's free cash flow for the twelve months ending Jun 30, 2026 was -$84.97M. For fiscal 2025 it was -$96.98M. The highest annual figure on record is -$11.03M in fiscal 2017.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$96.98M–
FY2024Dec 31, 2024-$93.50M–
FY2023Dec 31, 2023-$98.18M–
FY2022Dec 31, 2022-$61.55M–
FY2021Dec 31, 2021-$64.10M–
FY2020Dec 31, 2020-$42.54M–
FY2019Dec 31, 2019-$28.95M–
FY2018Dec 31, 2018-$19.06M–
FY2017Dec 31, 2017-$11.03M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$20.03M–
Q1 FY2026Mar 31, 2026-$21.53M–
Q4 FY2025Dec 31, 2025-$20.90M–
Q3 FY2025Sep 30, 2025-$22.52M–
Q2 FY2025Jun 30, 2025-$26.68M–
Q1 FY2025Mar 31, 2025-$26.89M–
Q4 FY2024Dec 31, 2024-$24.28M–
Q3 FY2024Sep 30, 2024-$22.41M–
Q2 FY2024Jun 30, 2024-$23.72M–
Q1 FY2024Mar 31, 2024-$23.09M–
Q4 FY2023Dec 31, 2023-$23.62M–
Q3 FY2023Sep 30, 2023-$22.14M–
Q2 FY2023Jun 30, 2023-$26.41M–
Q1 FY2023Mar 31, 2023-$26.01M-1865.7%
Q4 FY2022Dec 31, 2022-$25.33M–
Q3 FY2022Sep 30, 2022-$20.14M–
Q2 FY2022Jun 30, 2022-$17.55M–
Q1 FY2022Mar 31, 2022$1.47M–
Q4 FY2021Dec 31, 2021-$16.52M–
Q3 FY2021Sep 30, 2021-$16.86M–
Q2 FY2021Jun 30, 2021-$14.91M–
Q1 FY2021Mar 31, 2021-$15.80M–
Q4 FY2020Dec 31, 2020-$13.71M–
Q3 FY2020Sep 30, 2020-$8.07M-260.1%
Q2 FY2020Jun 30, 2020-$12.12M–
Q1 FY2020Mar 31, 2020-$8.65M–
Q4 FY2019Dec 31, 2019-$7.72M-185.0%
Q3 FY2019Sep 30, 2019$5.04M–
Q2 FY2019Jun 30, 2019-$14.20M–
Q1 FY2019Mar 31, 2019-$12.07M–
Q4 FY2018Dec 31, 2018$9.08M–
Q3 FY2018Sep 30, 2018-$10.75M–
Q2 FY2018Jun 30, 2018-$9.81M–
Q1 FY2018Mar 31, 2018-$7.58M–
Q4 FY2017Dec 31, 2017-$4.99M–
Q3 FY2017Sep 30, 2017-$3.85M–

More Adicet Bio figures

See a number that looks wrong?